0000899243-18-019865.txt : 20180713 0000899243-18-019865.hdr.sgml : 20180713 20180713210252 ACCESSION NUMBER: 0000899243-18-019865 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180531 FILED AS OF DATE: 20180713 DATE AS OF CHANGE: 20180713 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Poma Eric E CENTRAL INDEX KEY: 0001339484 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-32979 FILM NUMBER: 18953439 MAIL ADDRESS: STREET 1: C/O INNOVIVE PHARMACEUTICALS, INC. STREET 2: 555 MADISON AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Molecular Templates, Inc. CENTRAL INDEX KEY: 0001183765 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943409596 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9301 AMBERGLEN BLVD STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78729 BUSINESS PHONE: 512 896 1555 MAIL ADDRESS: STREET 1: 9301 AMBERGLEN BLVD STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78729 FORMER COMPANY: FORMER CONFORMED NAME: THRESHOLD PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020828 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2018-05-31 2018-06-04 0 0001183765 Molecular Templates, Inc. MTEM 0001339484 Poma Eric E C/O MOLECULAR TEMPLATES, INC. 9301 AMBERGLEN BLVD., SUITE 100 AUSTIN TX 78729 1 1 0 0 See Remarks Stock Option (right to buy) 6.31 2018-05-31 4 A 0 585126 0.00 A 2028-05-31 Common Stock 585126 585126 D 25% of the total number of shares subject to the option shall vest on May 31, 2019, and thereafter, the remaining 75% of the shares subject to the option shall vest pro rata on a monthly basis over 36 months. Chief Executive Officer and Chief Scientific Officer This amendment to Form 4 is filed to reflect that the correct number options granted in the reported transaction is 585,126. /s/ Eric E. Poma 2018-07-13